Concepedia

Thomas W. Hudyma

TW

Statistics

Publications

15

Citations

569

H-Index

14

Active since

1968

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Thomas W. Hudyma is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

1968–2014

15

Publications

15

Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase

Robert G. Gentles, Min Ding, John A. Bender et al. · Journal of Medicinal Chemistry · 2014 · 98 citations · Full text

Preparation and antiinflammatory properties of some 5-(2-anilinophenyl)tetrazoles

Peter F. Juby, Thomas W. Hudyma, Morton Brown · Journal of Medicinal Chemistry · 1968 · 62 citations

, , +17

Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: Synthesis and biological properties

Yasutsugu Ueda, John D. Matiskella, Jerzy Golik et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 57 citations

, , +8

Antiallergy agents. 1. 1,6-Dihydro-6-oxo-2-phenylpyrimidine-5-carboxylic acids and esters

Peter F. Juby, Thomas W. Hudyma, Myron Brown et al. · Journal of Medicinal Chemistry · 1979 · 47 citations

, , +13

Antiinflammatory activity of some indan-1-carboxylic acids and related compounds

Peter F. Juby, W. R. Goodwin, Thomas W. Hudyma et al. · Journal of Medicinal Chemistry · 1972 · 44 citations

, , +17

1–5 of 15